🎗️ Проект автоматически собирает и публикует онкологические новости из проверенных медицинских источников — 24/7, со ссылкой на первоисточник
Английские новости переводятся автоматически
Онкология

A new drug targeting KRAS, one of the key drivers of pancreatic cancer, is raising hopes after promising trial results. Rasonque has been approved in the USA, with a price tag of nearly $39,800 a month. Here’s why doctors are excited and what it could mean f - linkedin.com

A new drug targeting KRAS, one of the key drivers of pancreatic cancer, is raising hopes after promising trial results. Rasonque has been approved in the USA, with a price tag of nearly $39,800 a month. Here’s why doctors are excited and what it could mean f linkedin.com

Онкология

Experience builds confidence when it comes to speaking at meetings

Take a look at the Healio | OSN calendar page, and you will find more than three dozen meetings, symposia and summits that make up a year of ophthalmology gatherings. Whether they are one-room, single-day conferences, such as Clinical Trials at the Summit, or they take up full convention centers, such as the American…